Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector
The company has reported total income of Rs. 3276.35 crores during the period ended March 31, 2023
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
India’s efforts are aimed at boosting health at the last mile
These initiatives aim to improve access to healthcare for rare disease patients
Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries
Dr. Reddy's Laboratories has been issued a Form 483 with four observations
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
Subscribe To Our Newsletter & Stay Updated
